Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Canevari

Showing results (31-40 of 131) with videos related to

Pageof 14
Sort By:
Medical Reference Services Quarterly|August 3, 2010
Refocusing reference services outside the library building: one library's experienceIrene M Lubker, Margaret E Henderson, Catharine S Canevari, et al.
International Journal of Cancer|September 15, 1972
Cellular immunity to human breast carcinomaG Fossati, S Canevari, G Della Porta, et al.
Clinical & Experimental Metastasis|July 1, 1995
Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigensV Dolo, E Adobati, S Canevari, et al.
Tumori|January 1, 1977
Complement-dependent serum cytotoxicity of cancer patients studied by 51Cr release assay on human cancer linesJ G Puche, S Canevari, G Fossati, et al.
Tumori|December 31, 1987
The effect of human serum on the binding activity of radiolabelled monoclonal antibodiesS Camagni, S Canevari, M Ripamonti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2001
The humoral immune response to macrocyclic chelating agent DOTA depends on the carrier moleculeM E Perico, M Chinol, A Nacca, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1992
Possible targets on carcinoma for bMAb retargeting of lymphocyte or drug cytotoxicityS Canevari, D Mezzanzanica, S Ménard, et al.
Cancer Research|December 1, 1996
CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinomaA Mazzoni, D Mezzanzanica, G Jung, et al.
Hybridoma|January 1, 1986
Change in binding reactivity of an anti-tumor monoclonal antibody after the introduction of 2-pyridyl disulphide groupsR Orlandi, S Canevari, F Leoni, et al.
Hybridoma|January 1, 1986
Carbohydrate epitope defined by an antitumor monoclonal antibody detected on glycoproteins and a glycolipid by immunoblottingF Leoni, S Miotti, S Canevari, et al.
Pageof 14

Showing results (31-40 of 131) with videos related to

Sort By:
Pageof 14
Medical Reference Services Quarterly|August 3, 2010
Refocusing reference services outside the library building: one library's experienceIrene M Lubker, Margaret E Henderson, Catharine S Canevari, et al.
International Journal of Cancer|September 15, 1972
Cellular immunity to human breast carcinomaG Fossati, S Canevari, G Della Porta, et al.
Clinical & Experimental Metastasis|July 1, 1995
Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigensV Dolo, E Adobati, S Canevari, et al.
Tumori|January 1, 1977
Complement-dependent serum cytotoxicity of cancer patients studied by 51Cr release assay on human cancer linesJ G Puche, S Canevari, G Fossati, et al.
Tumori|December 31, 1987
The effect of human serum on the binding activity of radiolabelled monoclonal antibodiesS Camagni, S Canevari, M Ripamonti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2001
The humoral immune response to macrocyclic chelating agent DOTA depends on the carrier moleculeM E Perico, M Chinol, A Nacca, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1992
Possible targets on carcinoma for bMAb retargeting of lymphocyte or drug cytotoxicityS Canevari, D Mezzanzanica, S Ménard, et al.
Cancer Research|December 1, 1996
CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinomaA Mazzoni, D Mezzanzanica, G Jung, et al.
Hybridoma|January 1, 1986
Change in binding reactivity of an anti-tumor monoclonal antibody after the introduction of 2-pyridyl disulphide groupsR Orlandi, S Canevari, F Leoni, et al.
Hybridoma|January 1, 1986
Carbohydrate epitope defined by an antitumor monoclonal antibody detected on glycoproteins and a glycolipid by immunoblottingF Leoni, S Miotti, S Canevari, et al.
Pageof 14